Sarepta intends to use the net proceeds from the offering principally for the continuation and initiation of further clinical trials, commercialization, manufacturing, business development activities including the potential licensing or acquisition of complementary products and technologies and other general corporate purposes.
As far as I have seen there is no actual link to Sarepta? Just PYC making the links? Still it is nice to know they have the cash to buy PYC if they ever notice it.
Pre CR recommendations saying $200 for Sarepta - even a scrip bid would be good!
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)